February 28, 2023 — 04:11 pm EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Sarepta Therapeutics (SRPT) reported Loss for fourth quarter that decreased from the same period last year and  beat the Street estimates.
The company's earnings totaled -$109.24 million, or -$1.24 per share.  This compares with -$121.98 million, or -$1.42 per share, in last year's fourth quarter.
Excluding items, Sarepta Therapeutics reported adjusted earnings of -$46.53 million or -$0.53 per share for the period. 
Analysts on average had expected the company to earn -$1.35 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 28.3% to $258.43 million from $201.46 million last year.
Sarepta Therapeutics earnings at a glance (GAAP) :
-Earnings (Q4): -$109.24 Mln. vs. -$121.98 Mln. last year.
-EPS (Q4): -$1.24 vs. -$1.42 last year.
-Analyst Estimates: -$1.35
-Revenue (Q4): $258.43 Mln vs. $201.46 Mln last year.
 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.